Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2007 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ganesh, S.
Right arrow Articles by Seethamraju, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ganesh, S.
Right arrow Articles by Seethamraju, H.

Lung Transplantation


Monday, October 22, 2007

10:30 AM - 12:00 PM

A NOVEL CLINICAL PRESENTATION OF BRONCHIOLITIS OBLITERANS

Sivagini Ganesh, MD, MPH*, Ramesh Kesavan, MBBS, FCCP, Rajesh Shetty, MD, Tarik Haddad, MD, Karen L. Christos, RN and Harish Seethamraju, MBBS, MD

Baylor College of Medicine, Houston, TX

PURPOSE: To describe the significance of a unique clinical presentation of chronic rejection which resulted in rapidly declining lung function in lung transplant recipients.

METHODS: We prospectively reviewed patients who underwent lung transplantation in our institute from 2001 to 2005 and identified patients with a upper lobe predominant ground glass infiltrate and rapid decline in lung function with Bronchiolitis Obliterans.We also analyzed complications and outcomes of this unique clinical presentation of chronic rejection.

RESULTS: We reviewed 59 patients from 2001 to 2005. Demographics of this control group consisted 37(63%) males and 22(37%) females,IPF:26(44%),COPD: 18(30%),CF: 9(15%),PPH:5(9%) and sarcoidosis:1(2%). Among them 42(71%) had double and 17(29%) had single lung transplantation. Further analysis revealed 7 patients who developed organizing pneumonia especially in the upper lobes with rapidly declining lung function. All of them had double lung transplantation with a male predominance of 71% to 28%. The median age at diagnosis was 35 years, which is significantly younger age group compared to the control group. 72% (5/7) had a primary diagnosis of cystic fibrosis and 28%(2/7)had pulmonary fibrosis. Outcome analysis showed 4 among 7 died despite aggressive anti rejection treatment, 2 patients who underwent a re transplantation had steadily improving graft function and 1 patient lost to follow up. Of these patients most of them had eosinophilia in broncho alveolar lavage with CT evidence of a unique pattern of upper lobe pulmonary fibrosis with a relative sparing of the basal segments (Fig:1),autopsy on 4 patients revealed bronchiolitis obliterans and pulmonary function tests demonstrated a rapid decline in FEV1 among all the patients.

CONCLUSION: The novel presentation of chronic rejection with upper lobe fibrosis and rapid decline in graft function leading towards a poor outcome was noted in a younger age group of male Cystic Fibrosis patients who underwent double lung transplantation.

CLINICAL IMPLICATIONS: In view of rapidly progressive decline in lung function in this specific group of patients despite aggressive medical treatment, timely relisting and re transplantation should be considered.

DISCLOSURE: Sivagini Ganesh, No Financial Disclosure Information; No Product/Research Disclosure Information







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Chest Physicians.